Atlas Trials

A Real-world Study of Clinical Treatment Guidelines for Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan

Clinical trial NCT07465679 · COMPLETED

Trial details

NCT number
NCT07465679
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Study type
OBSERVATIONAL
Heart Failure With Reduced Ejection Fraction
Start date
2026-01-28
Primary completion
2026-03-10
Enrollment
2508

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.